GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine

At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally. These tools include the MINItrace Magni, the Omni Legend 21 cm, and the Clarify DL.

The MINItrace Magni is a cost-effective cyclotron used for in-house production of commercial PET tracers and radiometals through solid target technology. According to the company, this tool can help physicians identify and diagnose clinical signs across different care areas—such as oncology, cardiology, and neurology—when produced in combination with GE’s TRACERcenter (a PET radiopharmacy solution).

GE has also expanded its Omni platform with the Omni Legend 21 cm, a PET/CT that has the ability to evolve and help meet growing health care system demands across care areas. It can produce striking image quality in oncology, and it can accommodate increasing PET amyloid imaging volume related to Alzheimer diagnosis in neurology. It also produces “impressive” imaging of a variety of cardiac tracers, including fast decay tracers and new tracers in cardiology, according to the company.

In addition, GE has implemented the use of artificial intelligence (AI) into one of these new tools, the Clarify DL. It uses a new deep-learning reconstruction technology that reduces noise while maintaining contrast. According to GE, this AI-powered tool can deliver clear and accurate imaging compared to current noise reduction techniques, which typically lower contrast and resolution and may impact accuracy and diagnostic confidence.

“Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the health care system, but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities,” said the company.

Reference

GE HealthCare increases access to precision care tools, encouraging the continued adoption and practice of more personalized medicine around the world. News release; GE HealthCare. June 7, 2024. Accessed June 10, 2024. https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-increases-access-to-precision-care-tools-encouraging-the-continued-adoption-and-practice-of-more-personalized-medicine-around-the-world